Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Watching Cassava Sciences; Shares See Volume To The Upside As Traders Circulate Unconfirmed Analyst Comments Suggesting "Confirmed Guidance For Completion Of Its First Pivotal Alzheimer's Trial By Year-End 2024; Anticipating A Potential Settlement Of An SEC Investigation" Reiterating Their Buy Rating And $107 PT

Author: Benzinga Newsdesk | August 08, 2024 02:04pm

Posted In: SAVA